4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-25-005841
PRESIDENT AND CEO sold 19,688 shares at an average $27.78 ($546,914)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2025-02-21 | Sale 10b5-1 | −10,613 | $27.89 | $296,032 | 213,740 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2025-02-26 | Sale 10b5-1 | −7,975 | $27.55 | $219,732 | 205,765 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2025-02-26 | Sale 10b5-1 | −1,100 | $28.32 | $31,150 | 204,665 | D |
| Open-market sales · 19,688 sh · avg $27.78 · $546,914 | |||||||
Loading xslF345X05/form4-02272025_090225.xml…